Filovirus Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2026-03-20
Clinical Trial Update: Study of Obeldesivir as Postexposure Prophylaxis for Filovirus Diseases Virus Disease [Phase 2]
A Phase 2 study of Obeldesivir for postexposure prophylaxis of filovirus diseases has been withdrawn.